A single-center, retrospective, cohort study for routine use of Gemtuzumab Ozogamicin in newly diagnosed acute myeloid leukemia
Latest Information Update: 12 Jan 2021
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology